FUNDING AND PARTNERS
FUNDING
National Health and Medical Research Council of Australia:
The QSkin study is supported primarily through a Clinical Trials and Cohort Studies (CTCS) Grant from the NHMRC.
Funded by an NHMRC CTCS grant 2020–2024.
OUR PARTNERS
Melanoma Patients Australia:
We wish to acknowledge the assistance of Melanoma Patients Australia, their members and families, in overseeing the development of the QSkin study documents.
Skin Cancer College Australasia:
We wish to acknowledge the assistance of the Skin Cancer College Australasia for their active involvement with QSkin Genetics.
Infinity Path:
We wish to acknowledge the assistance of InfinityPath for their support of the QSkin Study.